Xin Nie Selected Research

Transcription Factors (Transcription Factor)

11/2020	ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15.
1/2017	Twist1 Enhances Hypoxia Induced Radioresistance in Cervical Cancer Cells by Promoting Nuclear EGFR Localization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Nie Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 05/2012
17	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 01/2018
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 03/2009
8	Neoplasm Metastasis (Metastasis) 10/2023 - 05/2014
7	Esophageal Squamous Cell Carcinoma 05/2024 - 01/2023
7	Inflammation (Inflammations) 06/2022 - 01/2013
6	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2016
6	Adenocarcinoma of Lung 08/2023 - 03/2018
5	Infections 01/2023 - 08/2013
5	Endometrial Neoplasms (Endometrial Cancer) 09/2021 - 01/2018
5	Carcinogenesis 06/2020 - 01/2017
4	Lung Neoplasms (Lung Cancer) 09/2023 - 01/2019
4	Myocardial Infarction 12/2021 - 01/2015
4	Carcinoma (Carcinomatosis) 01/2019 - 01/2017
3	Pain (Aches) 08/2023 - 08/2007
3	Nasopharyngeal Carcinoma 06/2020 - 01/2019
2	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 05/2024 - 01/2022
2	Cataract (Cataracts) 05/2024 - 01/2022
2	Weight Loss (Weight Reduction) 03/2024 - 01/2021
2	Esophageal Neoplasms (Esophageal Cancer) 03/2024 - 09/2023
2	COVID-19 07/2023 - 01/2023
2	Rheumatoid Arthritis 01/2023 - 06/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2022 - 07/2022
2	Stroke (Strokes) 01/2022 - 12/2021
2	Exanthema (Rash) 01/2021 - 12/2018
2	Diarrhea 01/2021 - 12/2018
2	Stomach Ulcer (Gastric Ulcer) 01/2021 - 01/2021
2	Hypoxia (Hypoxemia) 01/2018 - 01/2017
2	Infarction (Infarctions) 12/2017 - 01/2016
2	Chest Pain (Chest Pains) 11/2017 - 01/2016
2	Wounds and Injuries (Trauma) 01/2016 - 10/2009
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2015 - 11/2013
2	Acute Kidney Injury (Acute Renal Failure) 08/2013 - 01/2013
2	Hyperalgesia 08/2007 - 04/2005

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2009
9	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
7	ErbB Receptors (EGF Receptor)IBA 02/2022 - 06/2015
6	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
5	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2019
5	CytokinesIBA 01/2021 - 01/2017
5	MicroRNAs (MicroRNA)IBA 01/2020 - 09/2012
4	RNA (Ribonucleic Acid)IBA 08/2023 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 01/2017
4	Troponin T (Troponin T1)IBA 11/2017 - 01/2015
3	PhytochemicalsIBA 01/2024 - 01/2021
3	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2022
3	AfatinibIBA 08/2023 - 12/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022 - 05/2012
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 06/2015
3	Long Noncoding RNAIBA 04/2020 - 01/2020
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 10/2009
3	Competitive Endogenous RNAIBA 01/2020 - 01/2018
3	CollagenIBA 01/2016 - 11/2013
2	garcinone EIBA 01/2024 - 10/2023
2	LipidsIBA 12/2023 - 01/2019
2	Therapeutic UsesIBA 10/2023 - 03/2022
2	Glycyrrhetinic Acid (Po 12)IBA 06/2023 - 11/2022
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 02/2018
2	Antineoplastic Agents (Antineoplastics)IBA 11/2022 - 05/2012
2	Gefitinib (Iressa)FDA Link 02/2022 - 06/2015
2	osimertinibIBA 02/2022 - 12/2018
2	Bevacizumab (Avastin)FDA Link 01/2022 - 02/2014
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021 - 01/2020
2	SolutionsIBA 01/2021 - 11/2005
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2017
2	ChromatinIBA 11/2020 - 10/2017
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2020 - 01/2019
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2020 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2020
2	LigandsIBA 01/2019 - 05/2014
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2018 - 10/2014
2	Cyclin D1IBA 01/2018 - 10/2014
2	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 03/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2017 - 01/2016
2	SulfatasesIBA 12/2016 - 03/2016
2	Vascular Endothelial Growth Factor DIBA 12/2016 - 03/2016
2	tesmilifene (DPPE)IBA 06/2014 - 05/2012
2	PolymersIBA 05/2014 - 05/2012
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2014 - 08/2007
2	Hematoxylin (Haematoxylon)IBA 01/2014 - 08/2007
2	ProcalcitoninIBA 08/2013 - 01/2013
1	Dihydrotachysterol (AT 10)IBA 05/2024
1	Fibroins (Fibroin)IBA 03/2024
1	caprolactoneIBA 03/2024

Therapy/Procedure

14	Therapeutics 03/2024 - 10/2012
11	Drug Therapy (Chemotherapy) 11/2022 - 03/2009
6	Radiotherapy 05/2024 - 01/2017
6	Immunotherapy 11/2023 - 01/2019
4	Esophagectomy 05/2024 - 07/2023
3	Trabeculectomy (Trabeculoplasty) 05/2024 - 01/2022
3	Ligation 12/2023 - 01/2016
2	Chemoradiotherapy 05/2024 - 03/2024
2	Lymph Node Excision (Lymph Node Dissection) 09/2023 - 05/2023
2	Aftercare (After-Treatment) 08/2023 - 01/2022
2	Occlusal Splints 08/2023 - 01/2023
2	Decompression 01/2023 - 01/2022
1	Phacoemulsification 05/2024